Status:

ENROLLING_BY_INVITATION

5 Year Follow up of SMILE® Procedure for the Correction of Hyperopia

Lead Sponsor:

Gemini Eye Clinic

Conditions:

Hyperopia

Eligibility:

All Genders

Brief Summary

The planned study will investigate and evaluate refractive stability, predictability, and safety in patients who underwent SMILE® pro surgery for hyperopia with or without astigmatism at least five ye...

Eligibility Criteria

Inclusion

  • Patients who underwent the SMILE hyperopic procedure as part of the study referenced PHOBOS.
  • Patients should be able to understand the patient information and willing to sign an informed consent.
  • Patients should be willing to comply with all examinations during the visit.

Exclusion

  • Patients with severe ocular or generic disorders that would prevent them from completed the visit.
  • Patients not being able to understand and give informed consent.
  • Patients who did not underwent the SMILE hyperopic procedure as part of the study referenced PHOBOS.

Key Trial Info

Start Date :

January 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT07133737

Start Date

January 1 2025

End Date

December 31 2025

Last Update

August 21 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Gemini Eye Clinic

Zlín, Czechia, 76001

2

Universitätsklinikum Marburg - Klinik für Augenheilkunde

Marburg, Germany, 35043

5 Year Follow up of SMILE® Procedure for the Correction of Hyperopia | DecenTrialz